Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 5:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 385–408 of 992 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Insomnia Disorders Clear all

Conditions: Insomnia, Mild Cognitive Impairment
Interventions: Cognitive Training, Trivia Training; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 60 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Insomnia
Interventions: CBT-I; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 45 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Insomnia
Interventions: My Sleep Our Sleep (MSOS) Program; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Insomnia
Interventions: Mindfulness; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 20 Years to 50 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Insomnia
Interventions: zolpidem tartrate sublingual tablet, Placebo; Drug
Lead sponsor: Transcept Pharmaceuticals; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Stage, Breast Cancer
Interventions: Brief behavioral treatment for insomnia and bright light, treatment as usual; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 85 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Insomnia
Interventions: sham tES, Fixed tES, Personalized tES; Other
Lead sponsor: StimScience Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Alzheimer Disease, Sleep Initiation and Maintenance Disorders
Interventions: Walking Program, Light Exposure Program, Combined Education, Walking and Light Exposure Program, Routine Medical Care with Education; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 55 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Chronic Obstructive Pulmonary Disease, COPD
Interventions: Ramelteon and Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 21 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 6
States / cities: Birmingham, Alabama • Santa Monica, California • Miami Beach, Florida + 3 more

Conditions: Breast Cancer
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 50 Years and older · Female only
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Insomnia, Hypertension
Interventions: Brief Behavioral Treatment for Insomnia, Sleep Healthy Using the Internet, Enhanced Usual Care; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 100 Years
Enrollment: 542 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Primary Insomnia
Interventions: PD 0200390, Placebo; Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 16
States / cities: Glendale, Arizona • Phenoix, Arizona • Phoenix, Arizona + 12 more

Conditions: Primary Insomnia
Interventions: Zolpidem, Placebos; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 21 Years to 55 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Insomnia, Cancer-related Problem/Condition, Cancer-Related Syndrome
Interventions: Cognitive Behavioral Therapy for Insomnia; Behavioral
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 25 Years to 85 Years · Female only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Insomnia
Interventions: BBTI-MV, Information Control; Behavioral · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Bipolar Disorder, Insomnia, Hypersomnia, Sleep Problems
Interventions: Body Scan (BS) Meditation Intervention, Brief Supportive Psychotherapy (SP); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Primary Insomnia
Interventions: zolpidem; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 21 Years to 70 Years
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Sleep Deprivation
Interventions: Eye mask and ear plugs; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Attention Deficit Hyperactivity Disorder, INSOMNIA
Interventions: Daytrana; Drug
Lead sponsor: Cox Health Systems; Other
Eligibility: 6 Years to 12 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Springfield, Missouri

Conditions: Smoking, Nicotine, Tobacco, Addiction, Substance Use Disorders, Insomnia, Sleep
Interventions: Daridorexant 50 mg, Placebo; Drug · Other
Lead sponsor: Legacy Health System; Other
Eligibility: 18 Years to 55 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Chronic Low Back Pain (CLBP), Insomnia
Interventions: Cognitive-behavioral therapy for insomnia (CBTi), CBTi + Savoring Meditation, CBTi + Pain Education; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Pain, Back, Pain, Acute, Sleep Disorder, Sleep Disorders, Circadian Rhythm, Sleep, Sleep Deprivation, Insomnia
Interventions: Drug- free, non-invasive patch (FREEDOM or REM Patch) with haptic vibrotactile trigger technology (VTT) Other Names:, Sham Patch without haptic vibrotactile trigger technology (VTT); Device
Lead sponsor: SuperPatch Limited LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Tyrone, Georgia

Conditions: Insomnia
Interventions: NBI-34060; Drug
Lead sponsor: Neurocrine Biosciences; Industry
Eligibility: 18 Years to 64 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 4
States / cities: Atlanta, Georgia • New York, New York • Cincinnati, Ohio

Conditions: Insomnia Disorder
Interventions: Daridorexant, Non-orexin receptor antagonist insomnia medication, No insomnia medication; Drug · Other
Lead sponsor: Idorsia Pharmaceuticals Ltd.; Industry
Eligibility: 15 Years to 50 Years · Female only
Enrollment: 2,095 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Wilmington, Delaware

Search by objective public record fields.

Cognitive Training in Mild Cognitive Impairment

Cognitive Behavioral Therapy for Insomnia in People With Chronic Obstructive Pulmonary Disease(COPD)

Feasibility and Acceptability Study of My Sleep Our Sleep (MSOS) Program

Mindfulness Meditation for Insomnia

A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia

Prophylactic Treatment of Sleep/Fatigue Before and During Chemotherapy

The Assessment of Human Sleep and Its Functions

Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease

Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease

Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated Patients

Hypertension With Unsatisfactory Sleep Health

A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia

The Role of Partial Reinforcement in the Long Term Management of Insomnia

The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients

Brief Behavioral Treatment of Insomnia in Military Veterans: Phase 2 (BBTIMVII)

Mindfulness Therapy on Disrupted Sleep in Bipolar Disorder

Safety and Efficacy of Chronic Hypnotic Use

Improving Sleep Quality in Flap Patients in the SICU

Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHD

Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking

Resilience Enhancement Following Sleep Treatment

Relieving Pain and Improving Sleep: Evaluating Topical Pain Relief and Sleep Patches

An Exploratory Study of NBI-34060 Capsules and Next Day Functioning

Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)